Your browser doesn't support javascript.
loading
Preinvasive and invasive disease in women with cytological diagnosis of high-grade lesion and high-grade lesion cannot exclude microinvasion.
Kuperman, Nina de Siqueira; Russomano, Fábio Bastos; de Melo, Yara Lucia Mendes Furtado; Gomes, Saint Clair dos Santos.
Afiliação
  • Kuperman Nde S; Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fundação Oswaldo Cruz (IFF/Fiocruz), Av. Rui Barbosa, 716 - Flamengo, CEP 22250-020, Rio de Janeiro, Brazil. nskuperman@yahoo.com.br.
  • Russomano FB; Department of Gynecology, Colposcopy Clinic, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fundação Oswaldo Cruz (IFF/Fiocruz), Rio de Janeiro, Brazil. fabiorussomano@gmail.com.
  • de Melo YL; Department of Gynecology, Universidade Federal do Estado do Rio de Janeiro (HUGFF/UNIRIO), Rio de Janeiro, Brazil. yarafurtadorj@terra.com.br.
  • Gomes SC; Department of Clinical Research, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira, Fundação Oswaldo Cruz (IFF/Fiocruz), Rio de Janeiro, Brazil. scgomes@iff.fiocruz.br.
BMC Womens Health ; 15: 81, 2015 Oct 08.
Article em En | MEDLINE | ID: mdl-26449754
ABSTRACT

BACKGROUND:

Cervical cancer is the third most common cancer in Brazil and has a high potential for prevention and cure. The prevalence of invasive and preinvasive disease in women with cytological diagnosis of high-grade lesion - cannot exclude microinvasion (HSIL-micro) is not known.

METHODS:

This cross-sectional study used a cytology lab database to identify women with HSIL-micro and HSIL referred to two colposcopic units from June 2006 to December 2012. For each woman with HSIL-micro, four women with cytologic diagnosis of HSIL who met the inclusion criteria were identified. Data were obtained from review of medical records.

RESULTS:

Forty-seven patients with report of HSIL-micro and 188 patients with report of HSIL were included. The final diagnoses revealed a frequency of preinvasive lesions of 31.9 % (15/47) and 59.6 % (112/188) in patients with HSIL-micro and HSIL, respectively, while the frequency of invasive disease was 63.8 % (30/47) and 11.7 % (22/188), respectively. The HSIL-micro group showed prevalence of preinvasive or invasive disease 6.5 times greater (95 % CI = 1.6-5.7) and, for invasive disease, 2.4 times greater (95 % CI = 1.7-3.6) than the HSIL group.

CONCLUSION:

Higher risk of preinvasive and invasive lesions in women with cytologic diagnosis of HSIL-micro reinforces recommendations for immediate investigation.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged / Pregnancy País/Região como assunto: America do sul / Brasil Idioma: En Revista: BMC Womens Health Assunto da revista: SAUDE DA MULHER Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Brasil

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Colo do Útero Tipo de estudo: Diagnostic_studies / Guideline / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged / Pregnancy País/Região como assunto: America do sul / Brasil Idioma: En Revista: BMC Womens Health Assunto da revista: SAUDE DA MULHER Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Brasil